The potential explanation for this improvement could be related to the finding that the consumption of sulforaphane suppresses NLRP3 (which is predominantly expressed in macrophages and triggers immune responses), and which then decreases dectin-1 levels and other pro-inflammatory factors in individuals with T2D [35]. Here, NLRP3 is linked to type 2 diabetes mellitus.